AngioDynamics Inc. (ANGO)’s Financial Results Comparing With iRhythm Technologies Inc. (NASDAQ:IRTC)

Both AngioDynamics Inc. (NASDAQ:ANGO) and iRhythm Technologies Inc. (NASDAQ:IRTC) compete on a level playing field in the Medical Instruments & Supplies industry. We will evaluate their performance with regards to profitability, analyst recommendations, risk, dividends, earnings and valuation, institutional ownership.

Earnings & Valuation

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
AngioDynamics Inc. 19 4.71 36.76M 1.60 12.72
iRhythm Technologies Inc. 76 0.00 24.71M -1.87 0.00

In table 1 we can see AngioDynamics Inc. and iRhythm Technologies Inc.’s top-line revenue, earnings per share (EPS) and valuation.


Table 2 provides us AngioDynamics Inc. and iRhythm Technologies Inc.’s return on assets, net margins and return on equity.

Net Margins Return on Equity Return on Assets
AngioDynamics Inc. 196,788,008.57% 3.2% 2.4%
iRhythm Technologies Inc. 32,543,131.83% -76.4% -37.9%


AngioDynamics Inc.’s Current Ratio and Quick Ratio are 2.7 and 1.7 respectively. The Current Ratio and Quick Ratio of its competitor iRhythm Technologies Inc. are 3.3 and 3.2 respectively. iRhythm Technologies Inc. therefore has a better chance of paying off short and long-term obligations compared to AngioDynamics Inc.

Analyst Ratings

AngioDynamics Inc. and iRhythm Technologies Inc. Recommendations and Ratings are available in the next table.

Sell Ratings Hold Ratings Buy Ratings Rating Score
AngioDynamics Inc. 0 0 0 0.00
iRhythm Technologies Inc. 0 0 1 3.00

Meanwhile, iRhythm Technologies Inc.’s average target price is $80, while its potential upside is 7.98%.

Institutional and Insider Ownership

About 1.9% of AngioDynamics Inc.’s share are owned by insiders. On the other hand, insiders owned about 1.4% of iRhythm Technologies Inc.’s shares.


In this table we show the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

Performance (W) Performance (M) Performance (Q) Performance (HY) Performance (Y) Performance (YTD)
AngioDynamics Inc. -5.56% 2.62% 0.39% -2.07% -3.37% 1.24%
iRhythm Technologies Inc. -0.75% 7.65% 13.75% -3.04% 11.22% 19.66%

For the past year AngioDynamics Inc.’s stock price has smaller growth than iRhythm Technologies Inc.


AngioDynamics Inc. beats on 8 of the 12 factors iRhythm Technologies Inc.

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease, vascular access, and for use in oncology and surgical settings in the United States and internationally. The company provides manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases; VenaCure EVLT laser system products to treat superficial venous diseases; Asclera drug for treating uncomplicated spider and reticular veins of the lower extremities; and Sotradecol drugs for treating small uncomplicated varicose veins of the lower extremities. It also offers AngioVac venous drainage system that includes venous drainage cannula for the removal of fresh, soft thrombi, or emboli during extracorporeal bypass; and cardiopulmonary bypass circuit for use in procedures during extracorporeal circulatory support. In addition, the company provides thrombolytic catheters to deliver thrombolytic agents; angiographic products and accessories for use in during peripheral vascular interventional procedures; drainage products, which drain abscesses and other fluid pockets; and micro access sets. Further, it offers peripherally inserted central catheters; ports that are implantable devices for the central venous administration; and dialysis products. Additionally, the company provides microwave ablation products; radiofrequency ablation products for ablating solid cancerous or benign tumors; and NanoKnife ablation systems for the surgical ablation of soft tissues. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, and interventional and surgical oncologists directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.

iRhythm Technologies, Inc., a digital healthcare company, focuses on the provision of ambulatory electrocardiogram, or ECG, monitoring for patients at risk for arrhythmias in the United States. It offers ZIO Service, a platform that provides wearable biosensor with cloud-based data analytics that distill data from heartbeats into clinically actionable information. The company was founded in 2006 and is headquartered in San Francisco, California.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.